项目 | 替格瑞洛(n = 62) | 氯吡格雷(n = 57) | P值 |
靶病变失败 | 2 (3.23%) | 6 (10.53%) | 0.192 |
心源性死亡 | 0 (0.00%) | 4 (7.02%) | 0.044 |
靶血管心肌梗死 | 0 (0.00%) | 1 (1.75%) | 0.469 |
靶病变血运重建 | 2 (3.23%) | 1 (1.75%) | 1 |
MACE | 16 (25.81%) | 17 (29.82%) | 0.491 |
心源性死亡 | 0 (0.00%) | 4 (7.02%) | 0.044 |
复发心绞痛 | 17 (27.42%) | 17 (29.82%) | 0.772 |
急性心力衰竭 | 0 (0.00%) | 6 (10.53%) | 0.009 |
卒中 | 2 (3.23%) | 2 (3.51%) | 1 |
急性心肌梗死 | 1 (1.61%) | 3 (5.26%) | 0.348 |